203
Participants
Start Date
January 31, 2012
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
quadrivalent HPV vaccine
For the group who have received two prior doses of vaccine, the third and final dose of vaccine will be given. For the unvaccinated cohort, women will receive all three doses of the vaccine. The second dose of the vaccine will be given two months after the first dose. The third and final dose of the vaccine will be given six months after the first dose.
Emory University, Atlanta
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Emory University
OTHER